Cadence Pharmaceuticals CADX

By ZetaKap : Interested in biotechnology companies? Do you value companies holding large amounts of cash? Do you prefer stocks with high projected earnings over the next year? If so, you'll probably like this list. The Current ratio is a liquidity ratio used to determine a company's financial ...

(Reuters) - Cadence Pharmaceuticals Inc's shares fell to their life-low after the biopharmaceutical company reported a larger-than-expected first-quarter loss on costs related to the recall of its...

By Smith On Stocks : Investment Opinion and Overview Now is the moment of truth for Transcept ( TSPT ) as the launch of Intermezzo has begun. I recommended Transcept in a report published on January 24, 2012 and I continue to recommend the stock. I would suggest that investors who need a refresher

By Smith On Stocks : Investment Opinion, In Brief The PDUFA date for Levadex, MAP Pharmaceutical's ( MAPP ) lead product, is looming on March 26, 2012. I believe that there is a very high probability for approval and only a small chance for a Complete Response Letter. A CRL, if issued, would likely

… I was somewhat alarmed to see a press release entitled " Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection ". Cadence ( CADX ) is one of the stocks that I am recommending and my experience …

Cadence Pharmaceuticals ( CADX +0.1% ) voluntarily recalls some of its Ofirmev pain reliever injection vials after an unidentified particle was found in one of the lot's vials during routine stability testing. Post your comment!

By Andrew McDonald : In November of last year, Incyte Corporation ( INCY ) announced FDA approval for its oral JAK inhibitor, Jakafi (ruxolitinib),the first approved treatment for patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF and ...